loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Plinabulin, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Plinabulin

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass

    Inke S.A: APIs manufacturing plant.

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    2D Structure
    1. Also known as: 714272-27-2, Npi-2358, Plinabulin (npi-2358), Plinabulin(npi-2358), Npi-2358 (plinabulin), Npi 2358
    Molecular Formula
    C19H20N4O2
    Molecular Weight
    336.4  g/mol
    InChI Key
    UNRCMCRRFYFGFX-TYPNBTCFSA-N
    FDA UNII
    986FY7F8XR
    Plinabulin is an orally active diketopiperazine derivative with potential antineoplastic activity. Plinabulin selectively targets and binds to the colchicine-binding site of tubulin, thereby interrupting equilibrium of microtubule dynamics. This disrupts mitotic spindle assembly leading to cell cycle arrest at M phase and blockage of cell division. In addition, plinabulin may also inhibit growth of proliferating vascular endothelial cells, thereby disrupting the function of tumor vasculature that further contributes to a decrease in tumor cell proliferation.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (3Z,6Z)-3-benzylidene-6-[(5-tert-butyl-1H-imidazol-4-yl)methylidene]piperazine-2,5-dione
    2.1.2 InChI
    InChI=1S/C19H20N4O2/c1-19(2,3)16-13(20-11-21-16)10-15-18(25)22-14(17(24)23-15)9-12-7-5-4-6-8-12/h4-11H,1-3H3,(H,20,21)(H,22,25)(H,23,24)/b14-9-,15-10-
    2.1.3 InChI Key
    UNRCMCRRFYFGFX-TYPNBTCFSA-N
    2.1.4 Canonical SMILES
    CC(C)(C)C1=C(N=CN1)C=C2C(=O)NC(=CC3=CC=CC=C3)C(=O)N2
    2.1.5 Isomeric SMILES
    CC(C)(C)C1=C(N=CN1)/C=C\2/C(=O)N/C(=C\C3=CC=CC=C3)/C(=O)N2
    2.2 Other Identifiers
    2.2.1 UNII
    986FY7F8XR
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Mbri-001

    2. Npi 2358

    3. Npi-2358

    4. Npi2358

    2.3.2 Depositor-Supplied Synonyms

    1. 714272-27-2

    2. Npi-2358

    3. Plinabulin (npi-2358)

    4. Plinabulin(npi-2358)

    5. Npi-2358 (plinabulin)

    6. Npi 2358

    7. (3z,6z)-3-benzylidene-6-[(5-tert-butyl-1h-imidazol-4-yl)methylidene]piperazine-2,5-dione

    8. 986fy7f8xr

    9. Npi2358

    10. (3e,6e)-3-benzylidene-6-[(5-tert-butyl-1h-imidazol-4-yl)methylidene]piperazine-2,5-dione

    11. (3z,6z)-3-benzylidene-6-((5-(tert-butyl)-1h-imidazol-4-yl)methylene)piperazine-2,5-dione

    12. 2,5-piperazinedione, 3-((5-(1,1-dimethylethyl)-1h-imidazol-4-yl)methylene)-6-(phenylmethylene)-, (3z,6z)-

    13. Plinabulin [usan:inn]

    14. Plinabulina

    15. Plinabuline

    16. Plinabulinum

    17. Unii-986fy7f8xr

    18. Plinabulin [mi]

    19. Plinabulin [inn]

    20. Plinabulin (usan/inn)

    21. Plinabulin [usan]

    22. Kpu-2

    23. Plinabulin [who-dd]

    24. Schembl79095

    25. Mls006011262

    26. Chembl1096380

    27. Ex-a292

    28. Chebi:177413

    29. Dtxsid201031311

    30. Bpi 2358

    31. Bpi-2358

    32. Zinc3819466

    33. Bdbm50030765

    34. Mfcd18074510

    35. Nsc797934

    36. S1176

    37. Akos005145762

    38. Akos024463284

    39. Bcp9000994

    40. Ccg-264849

    41. Cs-0506

    42. Db05992

    43. Nsc-797934

    44. Ac-32812

    45. Hy-14444

    46. Smr004703013

    47. Bcp0726000116

    48. Sw219827-1

    49. D09655

    50. Brd-k99498722-001-01-8

    51. Q15269699

    52. (3z,6z)-6-benzylidene-3-((5-(1,1-dimethylethyl)-1h-imidazol-4- Yl)methylidene)piperazine-2,5-dione

    2.4 Create Date
    2006-10-25
    3 Chemical and Physical Properties
    Molecular Weight 336.4 g/mol
    Molecular Formula C19H20N4O2
    XLogP32.8
    Hydrogen Bond Donor Count3
    Hydrogen Bond Acceptor Count3
    Rotatable Bond Count3
    Exact Mass336.15862589 g/mol
    Monoisotopic Mass336.15862589 g/mol
    Topological Polar Surface Area86.9 Ų
    Heavy Atom Count25
    Formal Charge0
    Complexity597
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count2
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Indication

    Investigated for use/treatment in cancer/tumors (unspecified).

    5 Pharmacology and Biochemistry
    5.1 Mechanism of Action

    NPI-2358 is a vascular disrupting agent currently in clinical development for the treatment of cancer by Nereus. NPI-2358 is one of over 200 synthetic analogues that were prepared following the discovery of the compound Halimide isolated from a marine fungus. In preclinical models of cancer, including lung, breast, sarcoma, colon and prostate, NPI-2358 demonstrated potent and selective anti-tumor effects in combination with docetaxel and other oncology therapies, as well as single-agent efficacy in a number of orthotopic models. NPI-2358 interacts with soluble beta-tubulin and prevents the polymerization of tubulin without altering dynamic microtubule function of formed microtubules. As demonstrated in preclinical testing, this target profile results in a highly specific nanomolar cytotoxicity while reducing the side effects seen in first-generation VDAs due to cardiotoxicity, hemodynamic changes and neuropathies.

    Post Enquiry
    POST ENQUIRY